Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care.
Riek M, Scherer A, Möller B, Ciurea A, von Mühlenen I, Gabay C, Kyburz D, Brulhart L, von Kempis J, Mueller RB, Hasler P, Strahm T, von Känel S, Zufferey P, Dudler J, Finckh A.
Riek M, et al. Among authors: mueller rb.
Sci Rep. 2023 Oct 18;13(1):17776. doi: 10.1038/s41598-023-44841-w.
Sci Rep. 2023.
PMID: 37853058
Free PMC article.